Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Gains from Investment Securities (2016 - 2026)

Protara Therapeutics' Gains from Investment Securities history spans 14 years, with the latest figure at $7000.0 for Q1 2026.

  • Quarterly Gains from Investment Securities fell 99.86% to $7000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7000.0 through Mar 2026, down 99.86% year-over-year, with the annual reading at $1.7 million for FY2025, 70.15% down from the prior year.
  • Gains from Investment Securities came in at $7000.0 for Q1 2026, down from $1.7 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.7 million in Q4 2024 to a low of $3933.0 in Q2 2023.
  • The 5-year median for Gains from Investment Securities is $1.7 million (2025), against an average of $1.9 million.
  • Year-over-year, Gains from Investment Securities surged 38038.83% in 2024 and then plummeted 99.86% in 2026.
  • Protara Therapeutics' Gains from Investment Securities stood at $1.8 million in 2022, then soared by 58.63% to $2.9 million in 2023, then skyrocketed by 96.33% to $5.7 million in 2024, then plummeted by 70.15% to $1.7 million in 2025, then tumbled by 99.59% to $7000.0 in 2026.
  • Per Business Quant, the three most recent readings for TARA's Gains from Investment Securities are $7000.0 (Q1 2026), $1.7 million (Q4 2025), and $1.6 million (Q3 2025).